The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms

Clinical trial NCT00401245 · COMPLETED

Trial details

NCT number: NCT00401245
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Vasomotor Symptoms

Start date: 2006-12-01
Primary completion: 2008-01-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.